PEPG
PepGen Inc.
Price Chart
Latest Quote
$2.25
+0.00 (+0.00%)
Current Price
| Previous Close | $2.25 |
| Open | $2.19 |
| Day High | $2.27 |
| Day Low | $2.16 |
| Volume | 587,504 |
Stock Information
| Shares Outstanding | 69.17M |
| Total Debt | $16.56M |
| Cash Equivalents | $132.30M |
| Net Income | $-77.22M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $155.63M |
| EPS (TTM) | $-1.46 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $39.89M |
| Income | $-77.22M |
| Book/sh | $1.94 |
| Cash/sh | $1.91 |
| Employees | 59 |
Financial Ratios
| Quick Ratio | 14.76 |
| Current Ratio | 14.98 |
| Debt/Eq | 12.36 |
Returns & Margins
| ROA | -35.79% |
| ROE | -68.40% |
Ownership
| Insider Ownership | 0.23% |
| Institutional Ownership | 88.37% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.83 |
| P/B | 1.16 |
Analyst Data
| Recommendation | none |
| Target Price | $10.25 |
Technical Indicators
| SMA20 | $2.01 |
| SMA50 | $1.73 |
| SMA200 | $4.03 |
| RSI | 73.91 |
| ATR | 0.2079 |
| Shares Float | 36.05M |
| Short Float | 8.17% |
| Short Ratio | 6.41 |
| Volatility | 1.88 |
| Rel Volume | 0.55 |
Performance History
| Week | -3.85% |
| Month | +41.51% |
| Quarter | +34.73% |
| 6 Months | -56.31% |
| YTD | -68.62% |
| Year | +75.78% |
| 3 Years | -73.50% |
| 10 Years | -82.54% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $2.25 | 604,028 |
| 2026-07-16 | $2.25 | 993,900 |
| 2026-07-15 | $2.40 | 1,822,800 |
| 2026-07-14 | $2.44 | 2,122,800 |
| 2026-07-13 | $2.44 | 2,361,300 |
| 2026-07-10 | $2.34 | 2,384,100 |
| 2026-07-09 | $2.30 | 2,435,000 |
| 2026-07-08 | $1.99 | 1,003,200 |
| 2026-07-07 | $2.05 | 2,130,900 |
| 2026-07-06 | $1.89 | 802,900 |
| 2026-07-02 | $1.76 | 293,200 |
| 2026-07-01 | $1.81 | 346,300 |
| 2026-06-30 | $1.80 | 438,700 |
| 2026-06-29 | $1.78 | 375,100 |
| 2026-06-26 | $1.70 | 512,100 |
| 2026-06-25 | $1.71 | 253,500 |
| 2026-06-24 | $1.77 | 536,200 |
| 2026-06-23 | $1.82 | 462,500 |
| 2026-06-22 | $1.83 | 1,356,700 |
| 2026-06-18 | $1.79 | 692,200 |
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
đ° Latest News
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks âĸ 2026-05-20T13:35:02Z
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?
Insider Monkey âĸ 2026-05-18T04:49:40Z
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-05-13T16:00:04Z
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway
MarketBeat âĸ 2026-04-01T00:07:12Z
PepGen muscular dystrophy drug gets âsurpriseâ hold from FDA
BioPharma Dive âĸ 2026-03-05T10:59:00Z
How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44%
Zacks âĸ 2025-12-10T14:55:03Z
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
Zacks âĸ 2025-11-25T18:08:00Z
PepGen Inc.'s (NASDAQ:PEPG) largest shareholders are individual investors with 39% ownership, private equity firms own 36%
Simply Wall St. âĸ 2025-11-15T12:53:55Z
BofA Lifts PepGen (PEPG) PT to $3 on Positive DM1 Data Despite Underperform Rating
Insider Monkey âĸ 2025-10-26T10:06:01Z
PepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM Data
Insider Monkey âĸ 2025-09-30T15:50:18Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $93,612,000 | $97,739,000 | $84,766,000 | $68,301,000 |
| Other Income Expense | $-11,000 | $-1,000 | $-187,000 | $110,000 |
| Other Non Operating Income Expenses | $-11,000 | $-1,000 | $-187,000 | $110,000 |
| Net Non Operating Interest Income Expense | $4,017,000 | $7,142,000 | $6,400,000 | $2,793,000 |
| Operating Expense | $93,612,000 | $97,739,000 | $84,766,000 | $68,301,000 |
| General And Administrative Expense | $22,569,000 | $21,261,000 | $16,640,000 | $14,224,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Net Interest Income | $4,017,000 | $7,142,000 | $6,400,000 | $2,793,000 |
| Interest Income | $4,017,000 | $7,142,000 | $6,400,000 | $2,793,000 |
| Normalized Income | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Net Income From Continuing And Discontinued Operation | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Total Operating Income As Reported | $-93,612,000 | $-97,739,000 | $-84,766,000 | $-68,301,000 |
| Net Income Common Stockholders | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Net Income | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Net Income Including Noncontrolling Interests | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Net Income Continuous Operations | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Pretax Income | $-89,606,000 | $-90,598,000 | $-78,553,000 | $-65,398,000 |
| Interest Income Non Operating | $4,017,000 | $7,142,000 | $6,400,000 | $2,793,000 |
| Operating Income | $-93,612,000 | $-97,739,000 | $-84,766,000 | $-68,301,000 |
| Per Share | ||||
| Diluted EPS | $-2.12 | $-2.85 | $-3.30 | $-2.91 |
| Basic EPS | $-2.12 | $-2.85 | $-3.30 | $-2.91 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-88,467,000 | $-92,486,000 | $-83,916,000 | $-67,808,000 |
| Reconciled Depreciation | $5,145,000 | $5,253,000 | $850,000 | $493,000 |
| EBITDA (Bullshit earnings) | $-88,467,000 | $-92,486,000 | $-83,916,000 | $-67,808,000 |
| EBIT | $-93,612,000 | $-97,739,000 | $-84,766,000 | $-68,301,000 |
| Diluted Average Shares | $42,221,808 | $31,583,073 | $23,796,000 | $23,713,196 |
| Basic Average Shares | $42,221,808 | $31,583,073 | $23,796,000 | $23,713,196 |
| Diluted NI Availto Com Stockholders | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Tax Provision | $49,000 | $-617,000 | $73,000 | $3,706,000 |
| Research And Development | $71,043,000 | $76,478,000 | $68,126,000 | $54,077,000 |
| Selling General And Administration | $22,569,000 | $21,261,000 | $16,640,000 | $14,224,000 |
| Other Gand A | $22,569,000 | $21,261,000 | $16,640,000 | $14,224,000 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-07-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Total Assets | $173,907,000 | $150,883,000 | $143,052,000 | $217,440,000 |
| Total Non Current Assets | $22,944,000 | $27,122,000 | $30,374,000 | $31,357,000 |
| Other Non Current Assets | $1,920,000 | $1,974,000 | $1,990,000 | $1,473,000 |
| Current Assets | $150,963,000 | $123,761,000 | $112,678,000 | $186,083,000 |
| Other Current Assets | $2,507,000 | $3,570,000 | $2,271,000 | $4,331,000 |
| Cash Cash Equivalents And Short Term Investments | $148,456,000 | $120,191,000 | $110,407,000 | $181,752,000 |
| Cash And Cash Equivalents | $60,514,000 | $49,421,000 | $80,774,000 | $181,752,000 |
| Receivables | - | - | - | $58,000 |
| Other Receivables | - | - | - | $58,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $17,004,000 | $18,661,000 | $20,104,000 | $24,534,000 |
| Long Term Debt And Capital Lease Obligation | $13,817,000 | $15,567,000 | $17,100,000 | $18,981,000 |
| Current Debt And Capital Lease Obligation | $3,187,000 | $3,094,000 | $3,004,000 | $5,553,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $26,463,000 | $32,263,000 | $34,631,000 | $37,809,000 |
| Total Non Current Liabilities Net Minority Interest | $13,817,000 | $15,567,000 | $17,100,000 | $18,981,000 |
| Current Liabilities | $12,646,000 | $16,696,000 | $17,531,000 | $18,828,000 |
| Payables And Accrued Expenses | $4,796,000 | $9,985,000 | $12,159,000 | $10,835,000 |
| Payables | $822,000 | $1,752,000 | $1,005,000 | $3,936,000 |
| Accounts Payable | $822,000 | $1,752,000 | $1,005,000 | $1,362,000 |
| Total Tax Payable | - | - | $0 | $2,574,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Total Equity Gross Minority Interest | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Stockholders Equity | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Gains Losses Not Affecting Retained Earnings | $11,000 | $23,000 | $34,000 | $-81,000 |
| Other Equity Adjustments | $11,000 | $23,000 | $34,000 | $-81,000 |
| Retained Earnings | $-361,118,000 | $-271,463,000 | $-181,482,000 | $-102,856,000 |
| Preferred Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $68,874,944 | $32,619,663 | $23,823,241 | $23,713,196 |
| Share Issued | $68,874,944 | $32,619,663 | $23,823,241 | $23,713,196 |
| Tangible Book Value | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Invested Capital | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Working Capital | $138,317,000 | $107,065,000 | $95,147,000 | $167,255,000 |
| Capital Lease Obligations | $17,004,000 | $18,661,000 | $20,104,000 | $24,534,000 |
| Total Capitalization | $147,444,000 | $118,620,000 | $108,421,000 | $179,631,000 |
| Additional Paid In Capital | $508,544,000 | $390,057,000 | $289,867,000 | $282,566,000 |
| Capital Stock | $7,000 | $3,000 | $2,000 | $2,000 |
| Common Stock | $7,000 | $3,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $13,817,000 | $15,567,000 | $17,100,000 | $18,981,000 |
| Current Capital Lease Obligation | $3,187,000 | $3,094,000 | $3,004,000 | $5,553,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,663,000 | $3,617,000 | $2,368,000 | $2,440,000 |
| Current Accrued Expenses | $3,974,000 | $8,233,000 | $11,154,000 | $6,899,000 |
| Net PPE | $21,024,000 | $25,148,000 | $28,384,000 | $29,884,000 |
| Accumulated Depreciation | $-3,911,000 | $-3,046,000 | $-1,572,000 | $-389,000 |
| Gross PPE | $24,935,000 | $28,194,000 | $29,956,000 | $30,273,000 |
| Construction In Progress | $20,000 | $96,000 | $69,000 | $1,129,000 |
| Other Properties | $23,156,000 | $26,542,000 | $28,441,000 | $2,424,000 |
| Machinery Furniture Equipment | $1,759,000 | $1,556,000 | $1,446,000 | $171,000 |
| Other Short Term Investments | $87,942,000 | $70,770,000 | $29,633,000 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Leases | - | - | $23,620,000 | $26,549,000 |
| Properties | - | - | $0 | $0 |
Fetched: 2026-07-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-81,899,000 | $-82,869,000 | $-71,596,000 | $-63,020,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-81,635,000 | $-82,372,000 | $-68,997,000 | $-59,265,000 |
| Cash Flow From Continuing Operating Activities | $-81,635,000 | $-82,372,000 | $-68,997,000 | $-59,265,000 |
| Operating Gains Losses | - | - | - | $76,000 |
| Investing Activities | ||||
| Capital Expenditure | $-264,000 | $-497,000 | $-2,599,000 | $-3,755,000 |
| Investing Cash Flow | $-15,235,000 | $-37,668,000 | $-32,003,000 | $-3,755,000 |
| Cash Flow From Continuing Investing Activities | $-15,235,000 | $-37,668,000 | $-32,003,000 | $-3,755,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $108,100,000 | $86,778,000 | $0 | $114,267,000 |
| Financing Cash Flow | $107,979,000 | $88,749,000 | $-189,000 | $112,193,000 |
| Cash Flow From Continuing Financing Activities | $107,979,000 | $88,749,000 | $-189,000 | $112,193,000 |
| Net Other Financing Charges | $-413,000 | $-511,000 | $-442,000 | $-2,697,000 |
| Net Common Stock Issuance | $108,100,000 | $86,778,000 | $0 | $114,267,000 |
| Common Stock Issuance | $108,100,000 | $86,778,000 | $0 | $114,267,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $82,000 | $71,000 | $2,702,000 | $0 |
| End Cash Position | $62,062,000 | $50,969,000 | $82,322,000 | $183,225,000 |
| Beginning Cash Position | $50,969,000 | $82,322,000 | $183,225,000 | $134,368,000 |
| Effect Of Exchange Rate Changes | $-16,000 | $-62,000 | $286,000 | $-316,000 |
| Changes In Cash | $11,109,000 | $-31,291,000 | $-101,189,000 | $49,173,000 |
| Proceeds From Stock Option Exercised | $292,000 | $2,482,000 | $253,000 | $623,000 |
| Net Investment Purchase And Sale | $-14,971,000 | $-37,171,000 | $-29,404,000 | $0 |
| Sale Of Investment | $79,000,000 | $108,000,000 | $0 | - |
| Purchase Of Investment | $-93,971,000 | $-145,171,000 | $-29,404,000 | $0 |
| Net PPE Purchase And Sale | $-264,000 | $-497,000 | $-2,599,000 | $-3,755,000 |
| Purchase Of PPE | $-264,000 | $-497,000 | $-2,599,000 | $-3,755,000 |
| Change In Working Capital | $-6,223,000 | $-5,246,000 | $1,951,000 | $4,507,000 |
| Change In Other Current Liabilities | $-3,094,000 | $-3,004,000 | $-1,166,000 | $-2,016,000 |
| Change In Payables And Accrued Expense | $-4,203,000 | $-941,000 | $1,053,000 | $4,124,000 |
| Change In Accrued Expense | $-3,268,000 | $-1,663,000 | $1,422,000 | $5,531,000 |
| Change In Payable | $-935,000 | $722,000 | $-369,000 | $-1,407,000 |
| Change In Account Payable | $-935,000 | $722,000 | $-369,000 | $-1,407,000 |
| Change In Prepaid Assets | $1,074,000 | $-1,301,000 | $2,064,000 | $-1,784,000 |
| Stock Based Compensation | $10,609,000 | $11,457,000 | $7,048,000 | $4,763,000 |
| Asset Impairment Charge | $701,000 | $0 | - | - |
| Amortization Of Securities | $-2,212,000 | $-3,925,000 | $-220,000 | $0 |
| Depreciation Amortization Depletion | $5,145,000 | $5,253,000 | $850,000 | $493,000 |
| Depreciation And Amortization | $5,145,000 | $5,253,000 | $850,000 | $493,000 |
| Amortization Cash Flow | $3,748,000 | $3,748,000 | $-334,000 | $0 |
| Amortization Of Intangibles | $3,748,000 | $3,748,000 | $-334,000 | $0 |
| Depreciation | $1,397,000 | $1,505,000 | $1,184,000 | $493,000 |
| Net Income From Continuing Operations | $-89,655,000 | $-89,981,000 | $-78,626,000 | $-69,104,000 |
| Other Non Cash Items | - | $70,000 | - | $134,000 |
| Change In Receivables | - | - | $26,000 | $4,183,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $134,000 |
| Change In Other Current Assets | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $-58,000 |
Fetched: 2026-07-16